ROCHE ACETAMINOPHEN 03255379190

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a * report with the FDA on 2010-08-30 for ROCHE ACETAMINOPHEN 03255379190 manufactured by Roche Diagnostics.

Event Text Entries

[1353877] The customer alleged a significant bilirubin interference with the (b)(4) acetaminophen application. The customer received a questionable result for acetaminophen on the analytical p module for one patient sample collected from a transplant patient. The date of occurrence was not provided. The initial result for acetaminophen was 130 umol/l. This result was reported outside the laboratory. The bilirubin concentration for this sample was about 300 umol/l. A urine sample obtained from the patient was tested by (b)(6) and no acetaminophen was detected in this urine sample. The patient was treated with (nac) n-acetyl cysteine due to the questionable acetaminophen result of 130 umol/l. No adverse event has been alleged reagarding this event. The acetaminophen reagent lot number was not provided.
Patient Sequence No: 1, Text Type: D, B5


[1830785]
Patient Sequence No: 1, Text Type: D, B5


[8780339] The event occurred in (b)(6).
Patient Sequence No: 1, Text Type: N, H10


[8875229] An urgent medical device correction was issued containing the following information: the "limitations - interference" section of the acetaminophen package insert, e-package insert, and method sheets will be updated to more clearly indicate the impact of icteric, hemolytic, or lipemic samples with low levels of acetaminophen. The updated acetaminophen labeling (i. E. , package insert, e-package insert, and method sheets) will be made available as soon as possible. False positive acetaminophen results may be obtained for acetaminophen- free samples if an endogenous interferent (i. E. , bilirubin, hemolysis, or lipemia) is present. This may cause n-acetylcysteine treatment to be unnecessarily initiated in patients with elevated bilirubin concentrations. Since most of the patients seen within the first 24 hours of an acute acetaminophen overdose present with only slightly increased bilirubin concentrations, it is unlikely that false positive acetaminophen results will occur in the setting of acute acetaminophen toxicity. In patients with acute liver injury, the false positive results may lead to the incorrect clinical interpretation that the injury is caused by acetaminophen ingestion. Endogenous interferents (i. E. , bilirubin, hemolysis, and/or lipemia) may produce a falsely elevated value for samples containing concentrations less than 50 ug/ml of acetaminophen.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1823260-2010-05159
MDR Report Key1819493
Report Source*
Date Received2010-08-30
Date of Report2010-12-22
Date of Event2010-08-04
Date Mfgr Received2010-08-04
Date Added to Maude2010-12-22
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location3
Manufacturer ContactERIC KOLODZIEJ
Manufacturer Street9115 HAGUE ROAD
Manufacturer CityINDIANAPOLIS IN 46250
Manufacturer CountryUS
Manufacturer Postal46250
Manufacturer Phone3175212834
Manufacturer G1ROCHE DIAGNOSTICS GMBH
Manufacturer StreetSANDHOFERSTRASSE 118
Manufacturer CityMANNHEIM (BADEN-WURTTEMBERG) 68300
Manufacturer Postal Code68300
Single Use3
Previous Use Code3
Removal Correction Number1823260-11/18/10-002-C
Event Type3
Type of Report3

Device Details

Brand NameROCHE ACETAMINOPHEN
Generic NameCOLORIMETRY, ACETAMINOPHEN
Product CodeLDP
Date Received2010-08-30
Catalog Number03255379190
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerROCHE DIAGNOSTICS
Manufacturer Address9115 HAGUE RD. INDIANAPOLIS IN 46250 US 46250


Patients

Patient NumberTreatmentOutcomeDate
10 2010-08-30

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.